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of life (QoL) and the ability to work (WA) too. Till now in the Slovak Republic there 
was not realised the study oriented on the both mentioned categories. Methods: 
102 patients with LC were studied. The average of age was 50.3 y., weight – 78.3 kg, 
height – 175.1, duration of illness – 2.4 y., symptoms of illness before diagnosis – 1.2 
y. Metastases were present in 72 patients. 4 patients were mentioned as strong pes-
simists, 10 predominant pessimists, 9 neither pessimists nor optimists, 61 predomi-
nant optimists, and 18 strong optimists. QoL and the ability to work was evaluated 
by means of the numeric scale from 0 to 10 (0-the worst, 10- the best) by patients 
themselves. Results: The QoL was evaluated in these domains: in the time of good 
health – 8-21, in the time of diagnosis – 2.82, in the current time – 3.71. The WA had 
these results: in time of good health – 8.89, in the time of diagnosis – 5.08, and in 
the current time – 2.17. The impact of treatment on the QoL was 2.49 and on the 
patients families QoL it was 2.75. The willingness to pay for perfect cure was 92.35 € 
per month (the average salary in Slovakia in 2013 was 824 € ). ConClusions: LC has 
a great impact on QoL and on the WA too. There was a strong correlation between 
QoL and WA, although the WA has the later onset as QoL. Our research confirmed 
the importance of early diagnosis and high effective treatment of this disease.
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objeCtives: To validate the short version of the QLQ-C30 obtained for patients with 
non-small-cell lung cancer in patients with head and neck, prostate, breast or cervix 
cancer. Methods: We analysed data of 636 patients distributed: 237 diagnosed 
with head and neck cancer, 146 diagnosed with breast cancer, 140 diagnosed with 
cervix cancer and 113 diagnosed with prostate cancer. The analysis followed a 4-step 
approach. First, we conducted a Mokken nonparametric item response analysis 
to ascertain the QLQ-C30 dimensionality and separate several scale if appropri-
ate. Second, we conducted a parametric Samejima’s graded response model (GRM) 
to assess the item characteristics and information for each scale. Third, we did 
a confirmatory factor analysis (CFA) to test the scales unidimensionality and to 
obtain standardised factor loadings to suggest a reduced version of the QLQ. Finally, 
we assessed the discriminative validity of the reduced version by using receiver-
operator curve (ROC) analysis. Results: Mokken analysis of the QLQ-C30 resulted 
in a unidimensional scale, with an overall scalability defined a medium scale. The 
unconstrained GRM showed that most items presented appropriate difficulty and 
discrimination parameters. The CFA supported an underlying unidimensional 
latent structure for the whole QLQ-C30 (CFI = 0.98; RMSEA = 0.05) with modifica-
tion indexes pointing to important redundancy of information. The selection of 
items with standardized factor loadings > 0.70 lead to a 6-item QLQ that showed 
good discriminative validity against independent criteria of quality of life (ROC 
area = 0.76; 95% CI = 0.72 to 0.80) as compared with the values for the whole scale 
(ROC area = 0.70; 95% CI = 0.66 to 0.74). ConClusions: The EORTC reduced scale 
was validated in this study; it presents good psychometric properties and includes 
a unidimensional structure of patient-perceived quality of life.
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objeCtives: Surgery for breast cancer has a substantial impact on a woman’s 
health-related quality of life (HR-QOL). The NIH and EORTC advocate treatment 
with breast conserving therapy (BCT) for women with early stage breast cancer. The 
aim of this study was to understand the shared surgical decision-making process 
from the patients’ perspective by implementing qualitative methods. Methods: 
All participants were recruited and consented from a single center. Inclusion criteria 
included women who selected BCT over mastectomy. Utilizing an interview guide, 
women were asked to share their experience with all aspects of decision-making 
related to breast cancer treatment. Interviews were audio-taped, transcribed, and 
coded with NVIVO8. Qualitative data were further analyzed to identify factors 
influencing decision-making regarding BCT. A comparative matrix analysis was 
conducted to further evaluate women’s appraisal of their surgical decision-mak-
ing process and how this impacted their long-term HR-QOL. Results: Nineteen 
patients were included in the analysis. The mean age was 58.3 (+ 12.2) years, 52.9% 
were married, 84.2% were Caucasian, 68.4% were currently employed and 31.6% 
had a family history of breast cancer, 10.4% diagnosed with Stage 0, 52.6% stage 
I and 36.8% stage II breast cancer. Factors contributing to decision-making were 
dichotomized into satisfied (n= 11) or dissatisfied (n= 8). Satisfied patients were 
further categorized as either (i) positive outlook n= 2; (ii) acceptance of choice n= 9; 
Dissatisfied patients were further categorized as (i) experiencing regret n= 4; (ii) fear 
of recurrence n= 4. ConClusions: As decision-making needs vary by individual 
women, a personalized decision-making approach is an essential factor to improve 
HR-QOL among women with early stage breast cancer. Additional prospective quan-
titative studies of the preoperative decision-making and post-operative HR-QOL are 
necessary, as these findings may compliment existing outcomes research.
CaNCer – health Care use & Policy studies
PCN212
eVideNCe-based MediCiNe as a driVer of iMProViNg ColoreCtal 
CaNCer sCreeNiNg iN ukraiNe
Rubtsova I.1, Melnyk Y.2
1State Expert Center of the Ministry of Health of Ukraine, Kyiv, Ukraine, 2The State Expert Center 
of the Ministry of Health of Ukraine, Kyiv, Ukraine
1) estimate each patient’s longitudinal HRQoL trajectory before the first SRE using 
repeated measures analysis; 2) calculate how SREs affect HRQoL changes. Results: 
We found statistically significant declines in utility scores after all three types of 
SREs with an adjusted mean change of -0.06 (95% CI [-0.10, -0.02]) for “radiotherapy/
surgery” (N= 107), -0.20 (95% CI [-0.36, -0.04]) for “fractures” (N= 31) and -0.24 (95% 
CI [-0.39, -0.08]) for “compression” (N= 23). “Fractures” and “compression” affected 
a number of FACT-P domains and total score to a clinically meaningful and statisti-
cally significant extent. Compression had the broadest impact, affecting 7 out of 9 
FACT-P domains and induced a mean decrease in the FACT-P total score of -16.96 
(95% CI [-26.47, -7.44]). Radiotherapy/surgery was associated with a statistically 
significant decline in physical (-1.28, 95% CI [-2.06, -0.50]) and functional well being 
(-1.51, 95% CI [-2.37, -0.64]), and improvement in social well being (1.26, 95% CI [0.60, 
1.91]). Full results will be presented. ConClusions: The presence of SREs was 
significantly associated with poorer HRQoL in this patient population. Any therapy 
reducing or delaying the occurrence of SREs may slow down the observed HRQoL 
decline in mCRPC patients.
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objeCtives: Patients diagnosed with prostate cancer (PCa) have similar survival 
rates across treatments, making treatments choices based on health related quality 
of life (HRQoL) more important. Objective was to increase HRQoL usage, sustain-
ability and reliability measurement over time for use in cost–effectiveness analyses 
by investigating the occurrence of response shift (RS) in PCa patients. Never before 
has RS been measured over this long a time in PCa patients, not limited by few 
available treatment options. Methods: A prospective cross sectional cohort study 
was started in January of 2012 with 1,720 CAPSURE patients using the SF-36 and 
UCLA-Prostate Cancer Index (PCI). In January of 2012 patient were asked to fill out 
questionnaires asking about their perceived HRQoL at time of diagnosis (then score) 
and current HRQoL (post-score). These scores were matched to previous collected 
scores at baseline (pre-score), ranging from 3 months to 20 years. RS (then-pre score), 
True Change (TC= post-then score) and Felt Change (FC= post-then) were calculated 
and compared with t-tests in different questionnaire domains. Linear regression 
was used to explore relations between scores and patient characteristics. Results: 
RS and FC are found to be negative overall for SF-36 (RS:-3.6/-14.5 TC:-8.1/1.8 
FC:-3.0/-22.7) and PCI (RS:-4.0/-30.2 TC:-20.2/0.07 FC:-3.6/-49.8), showing significant 
difference (P< 0.05). Significant difference was also seen over the whole time range 
between post-scores and RS-adjusted-post-scores for SF-36 and PCI. A difference 
was found between recurrence and non-recurrence in both questionnaires (ranging 
0/-4.0), although not significant. RS over time did not show change. ConClusions: 
Mean negative RS scores were found in this population using SF-36 and PCI, indi-
cating over reporting in retrospective collected data. It is recommended physicians 
and researchers adjust found HRQoL scores with RS values found in this study, 
to increase usage, sustainability and reliability of retrospective collected HRQoL-
scores. Further research is needed to investigate RS dependency on other variables 
or characteristics.
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objeCtives: Multiple myeloma is common in older adults and its incidence increases 
after the age of 60 (under the age of 40, it occurs rarely, < 2%). In SK approx. 400 new 
cases have been diagnosed and in the treatment there is in average 1500 patients. 
Research aim was to find out the impact of the disease on particular items of Quality 
of patients´ lives. Methods: Sample: research consisted of pacienti diagnosed with 
the disease of multiple myeloma. We distributed 120 questionnaires and compiled 82 
questionnaires (68,33%). There were 36 men (43,90%) and 46 women (56,10%). Their age 
was between 40 and more. We utilised standardised questionnaire of quality of life, 
Quality of Life-BREF (WHOQOL-BREF). Its first part included 24 items in four domains 
(physical health, psychological health, social relationships, and environment) and two 
items of overall evaluation. Numerical scales were signed in the answers in the follow-
ing way: the least auspicious answer had the smallest value and the most auspicious 
answer had the biggest numerical value (range 1 – 5). The results of respondents were 
compared to population norms of the WHOQOL-BREF domains. Results: In majority 
of items, the answers of the respondents do not differ very much in comparison with 
the average score of WHOQOL-BREF. Two items mostly differ from the average score 
most: domain of physical health – pain, where the average of 2.5 lowered in compari-
son to population norm of 4.03. The domain psychological health – negative emo-
tions: where the average of 2.00 was lower in comparison to the population norm of 
3.47. ConClusions: Prompt diagnostics of multiple myeloma significantly increases 
the possibility of the treatment to be successful. It also prolongs and improves quality 
of patient life. Research finding points out the reality that MM does not have the same 
impact on all domains of quality of life.
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objeCtives: The current incidence and mortality of lung cancer (LC) in adult 
patients in Slovakia ranges from about 57.3 resp. 50.3 in men and 10.6 resp. 7.6 
in women per 100000 inhabitants. The lung cancer has a great impact on quality 
